DCEP an alternative to standard regimen in myeloma

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1462, 2004-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CAD regimen effective in advanced multiple myeloma

By  

Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Aprepitant an advance on standard antiemetic regimen for MEC

By  

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Bortezomib beats standard therapy in relapsed multiple myeloma

By  

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Misoprostol may be an alternative to standard oxytocics

By  

Inpharma, Vol. 1, Iss. 1257, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

A pharmacokinetic/pharmacodynamic analysis of a standard voriconazole regimen in different CYP2C19 genotypes by Monte Carlo simulation

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 5, 2015-01 ,pp. : 306-309

Govi-Verlag

Access to resources Recommend Favorite